PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
-1.75%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$1.81B
AUM Growth
-$55.5M
(-3%)
Cap. Flow
+$877K
Cap. Flow
% of AUM
0.05%
Top 10 Holdings %
Top 10 Hldgs %
31.67%
Holding
1,104
New
38
Increased
236
Reduced
694
Closed
136
Top Buys
| 1 |
Broadcom
AVGO
|
$6.48M |
| 2 |
Costco
COST
|
$4.36M |
| 3 |
PepsiCo
PEP
|
$4.02M |
| 4 |
Adobe
ADBE
|
$3.79M |
| 5 |
Cisco
CSCO
|
$3.39M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$14.1M |
| 2 |
Microsoft
MSFT
|
$14M |
| 3 |
Amazon
AMZN
|
$10.6M |
| 4 |
Tesla
TSLA
|
$6.62M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$4.66M |
Sector Composition
| 1 | Technology | 38.18% |
| 2 | Healthcare | 14.97% |
| 3 | Consumer Discretionary | 11.55% |
| 4 | Communication Services | 9.62% |
| 5 | Energy | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
BridgeBio Pharma
BBIO
$10.2B
| $1.42M | 0.08% |
53,869
-40,596
| -43% | -$1.07M |
|
202
Krystal Biotech
KRYS
$4.35B
| $1.42M | 0.08% |
12,240
+2,375
| +24% | +$276K |
|
203
Stryker
SYK
$150B
| $1.42M | 0.08% |
5,189
-21
| -0.4% | -$5.74K |
|
|
SAGE
204
DELISTED
Sage Therapeutics
SAGE
| $1.41M | 0.08% |
68,755
+43,076
| +168% | +$887K |
|
205
Freeport-McMoran
FCX
$66.5B
| $1.41M | 0.08% |
37,922
-2,535
| -6% | -$94.5K |
|
206
Recursion Pharmaceuticals
RXRX
$2.01B
| $1.41M | 0.08% |
184,235
+124,621
| +209% | +$953K |
|
207
GoDaddy
GDDY
$20.1B
| $1.41M | 0.08% |
18,899
+3,681
| +24% | +$274K |
|
208
PG&E
PCG
$33.2B
| $1.4M | 0.08% |
87,036
+18,923
| +28% | +$305K |
|
209
ZTO Express
ZTO
$14.7B
| $1.39M | 0.08% |
57,444
+6,674
| +13% | +$161K |
|
210
Philip Morris
PM
$251B
| $1.39M | 0.08% |
14,984
-1,884
| -11% | -$174K |
|
211
Cloudflare
NET
$74.7B
| $1.39M | 0.08% |
21,982
+251
| +1% | +$15.8K |
|
212
Wheaton Precious Metals
WPM
$47.3B
| $1.38M | 0.08% |
33,998
-2,418
| -7% | -$98.1K |
|
213
Beam Therapeutics
BEAM
$2.11B
| $1.38M | 0.08% |
57,317
+10,163
| +22% | +$244K |
|
214
CVS Health
CVS
$93.6B
| $1.38M | 0.08% |
19,712
-64
| -0.3% | -$4.47K |
|
215
GE Aerospace
GE
$296B
| $1.38M | 0.08% |
15,599
-275
| -2% | -$24.3K |
|
216
KE Holdings
BEKE
$22.4B
| $1.37M | 0.08% |
88,378
+3,310
| +4% | +$51.4K |
|
217
Roivant Sciences
ROIV
$8.82B
| $1.35M | 0.07% |
116,009
-11,869
| -9% | -$139K |
|
218
Monolithic Power Systems
MPWR
$41.5B
| $1.35M | 0.07% |
2,932
+210
| +8% | +$97K |
|
219
Cytokinetics
CYTK
$6.34B
| $1.35M | 0.07% |
45,879
+447
| +1% | +$13.2K |
|
220
S&P Global
SPGI
$164B
| $1.35M | 0.07% |
3,693
-130
| -3% | -$47.5K |
|
|
KRTX
221
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.34M | 0.07% |
7,934
+1,454
| +22% | +$246K |
|
222
Trip.com Group
TCOM
$47.6B
| $1.34M | 0.07% |
38,261
-249
| -0.6% | -$8.71K |
|
223
Apellis Pharmaceuticals
APLS
$3.55B
| $1.34M | 0.07% |
35,153
+18,766
| +115% | +$714K |
|
224
CRISPR Therapeutics
CRSP
$4.99B
| $1.33M | 0.07% |
29,268
+5,184
| +22% | +$235K |
|
225
Petrobras Class A
PBR.A
$72.8B
| $1.32M | 0.07% |
96,171
-9,750
| -9% | -$134K |
|